Key Financial’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.93K Hold
180
– – ﹤0.01% 1038
2026
Q2
$6.52K Hold
180
– – ﹤0.01% 964
2026
Q1
$5.95K Hold
180
– – ﹤0.01% 998
2025
Q4
$8.33K Hold
180
– – ﹤0.01% 926
2025
Q3
$6.33K Hold
180
– – ﹤0.01% 986
2025
Q2
$5.32K Hold
180
– – ﹤0.01% 1016
2025
Q1
$5.37K Hold
180
– – ﹤0.01% 979
2024
Q4
$5.16K Hold
180
– – ﹤0.01% 982
2024
Q3
$6.96K Hold
180
– – ﹤0.01% 885
2024
Q2
$5.8K Hold
180
– – ﹤0.01% 922
2024
Q1
$6.99K Hold
180
– – ﹤0.01% 849
2023
Q4
$5.54K Hold
180
– – ﹤0.01% 894
2023
Q3
$4.02K Hold
180
– – ﹤0.01% 981
2023
Q2
$3.87K Buy
+180
New +$4.09K ﹤0.01% 1027

Other funds holding COLL

Key Financial's COLL Position: Q3 2026 in Review

Key Financial held its Collegium Pharmaceutical (COLL) position steady in Q3 2026 at 180 shares worth $3.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Key Financial first reported a position in COLL in Q2 2023 and has held it in 14 quarters since. The position peaked at $8.33K in Q4 2025. 185 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Key Financial held 180 shares of Collegium Pharmaceutical worth $3.93K as of Q3 2026.
  • Key Financial left its Collegium Pharmaceutical share count unchanged in Q3 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1038 holding.
  • Key Financial first reported a position in Collegium Pharmaceutical in Q2 2023 and has held it in 14 quarters since.
  • Key Financial's Collegium Pharmaceutical position peaked at $8.33K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.